About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Efficacy and Safety With Ziprasidone in First-episode Psychosis

Efficacy and Safety With Ziprasidone in First-episode Psychosis

NCT01157559·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Chonbuk National University Hospital

With

Pfizer

Age

14–45

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients who meet DSM-IV criteria for first episode schizophrenia, schizophreniform disorder and schizoaffective disorder

You may not be if

Patients with previously prescribed antipsychotic medication in 2 weeks or more
patients with substance-induced psychotic disorder, serious suicide attempt, neurological disorder, etc.

The record

StatusCompleted

PhasePhase 4

Taking part27

Started—

UpdatedJul 7, 2010

Conditions

First Episode Psychosis

Where3

Department of Psychiatry, Chonbuk national University Hospital
Jeonju, South Korea
Heo psychiatric Hospital
Jeonju, South Korea
Jeonju Jesus Hospital
Jeonju, South Korea